English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 852324      Online Users : 1530
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    Siblings
    圖書 [1/1]
    會議論文/會議摘要 [115/179]

    Collection Statistics

    近3年內發表的文件:58(17.58%)
    含全文筆數:327(99.09%)

    文件下載次數統計
    下載大於0次:327(100.00%)
    下載大於100次:311(95.11%)
    檔案下載總次數:137594(77.78%)

    最後更新時間: 2024-11-28 12:19


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 76-100 of 330. (14 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2021-04-28 Inhibition of Beta-catenin activity abolishes LKB1 loss-driven pancreatic cystadenoma in mice International Journal of Molecular Sciences. 2021 Apr 28;22(9):Article number 4649.
    2021-04-12 An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan Scientific Reports. 2021 Apr 12;11:Article number 7881.
    2021-04 Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors Oncologist. 2021 Apr;26(4):e567-e579.
    2021-03-01 Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors Scientific Reports. 2021 Mar 1;11:Article number 4834.
    2021-03 A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma Oncologist. 2021 Mar;26(3):e367-e373.
    2021-01-13 Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials Biomolecules. 2021 Jan 13;11(1):Article number 97.
    2021-01 c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation Cancer Science. 2021 Jan;112(1):243-253.
    2021-01 Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1 Pancreatology. 2021 Jan 10;21(1):192-199.
    2020-12-29 Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan PLoS ONE. 2020 Dec 29;15(12):Article number e0244487.
    2020-11-13 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.] Scientific Reports. 2020 Nov 13;10:Article number 20199.
    2020-10 Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study Liver International. 2020 Oct;40(10):2535-2543.
    2020-07-01 A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue Haematologica. 2020 Jul 1;105(7):e349-e354.
    2020-07 JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions Annals of Oncology. 2020 Jul;31(7):861-872.
    2020-05-26 Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan Journal of Biomedical Science. 2020 May 26;27:Article number 69.
    2020-05-04 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort Scientific Reports. 2020 May 4;10:Article number 7420.
    2020-05 A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data Gastric Cancer. 2020 May;23(3):510-519.
    2020-05 Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in patients with pretreated biliary tract cancer Journal for ImmunoTherapy of Cancer. 2020 May;8(1):Article number e00056.
    2020-04 Management of early stage gastro-oesophageal cancers: Expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty Expert Review of Anticancer Therapy. 2020 Apr;20(4):305-324.
    2020-04 Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours British Journal of Cancer. 2020 Apr;122(9):1324-1332.
    2020-03 Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO Annals of Oncology. 2020 Mar;31(3):334-351.
    2020-02 Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Cancer Science. 2020 Feb;111(2):513-527.
    2020-01 Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Gastric Cancer. 2020 Jan;23(1):143-153.
    2020-01 Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer [Erraturm: Oncogene. 2016 May;35(12):1517-1528.] Oncogene. 2020 Jan;39(4):946-949.
    2020-01 A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study European Journal of Cancer. 2020 Jan;124:123-130.
    2020-01 Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial Pancreas. 2020 Jan;49(1):62-75.

    Showing items 76-100 of 330. (14 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback